vs
Astrana Health, Inc.（ASTH）与Essex Property Trust（ESS）财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是Essex Property Trust的2.0倍（$950.5M vs $479.6M），Essex Property Trust净利率更高（17.9% vs 0.7%，领先17.2%），Astrana Health, Inc.同比增速更快（42.9% vs 5.5%），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs 6.0%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
Essex Property Trust是一家公开上市的房地产投资信托企业，重点布局美国西海岸优质不动产市场，核心投资标的为加利福尼亚州及西雅图大都会区的公寓类物业，在长租公寓的投资、运营及管理领域拥有深厚的行业积累与资源优势。
ASTH vs ESS — 直观对比
营收规模更大
ASTH
是对方的2.0倍
$479.6M
营收增速更快
ASTH
高出37.4%
5.5%
净利率更高
ESS
高出17.2%
0.7%
两年增速更快
ASTH
近两年复合增速
6.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $479.6M |
| 净利润 | $6.6M | $85.7M |
| 毛利率 | — | 70.0% |
| 营业利润率 | 1.9% | 31.7% |
| 净利率 | 0.7% | 17.9% |
| 营收同比 | 42.9% | 5.5% |
| 净利润同比 | 184.4% | -71.6% |
| 每股收益（稀释后） | $0.12 | $1.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHESS
| Q4 25 | $950.5M | $479.6M | ||
| Q3 25 | $956.0M | $473.3M | ||
| Q2 25 | $654.8M | $469.8M | ||
| Q1 25 | $620.4M | $464.6M | ||
| Q4 24 | $665.2M | $454.5M | ||
| Q3 24 | $478.7M | $450.7M | ||
| Q2 24 | $486.3M | $442.4M | ||
| Q1 24 | $404.4M | $426.9M |
净利润ASTHESS
| Q4 25 | $6.6M | $85.7M | ||
| Q3 25 | $373.0K | $172.7M | ||
| Q2 25 | $9.4M | $231.5M | ||
| Q1 25 | $6.7M | $212.8M | ||
| Q4 24 | $-7.8M | $301.7M | ||
| Q3 24 | $16.1M | $125.5M | ||
| Q2 24 | $19.2M | $99.0M | ||
| Q1 24 | $14.8M | $285.1M |
毛利率ASTHESS
| Q4 25 | — | 70.0% | ||
| Q3 25 | — | 69.2% | ||
| Q2 25 | — | 70.7% | ||
| Q1 25 | — | 69.6% | ||
| Q4 24 | — | 70.0% | ||
| Q3 24 | — | 69.5% | ||
| Q2 24 | — | 70.8% | ||
| Q1 24 | — | 69.7% |
营业利润率ASTHESS
| Q4 25 | 1.9% | 31.7% | ||
| Q3 25 | 2.0% | 44.5% | ||
| Q2 25 | 3.1% | 59.5% | ||
| Q1 25 | 3.3% | 55.3% | ||
| Q4 24 | 0.1% | 67.0% | ||
| Q3 24 | 5.9% | 28.6% | ||
| Q2 24 | 6.2% | 31.1% | ||
| Q1 24 | 7.5% | 31.0% |
净利率ASTHESS
| Q4 25 | 0.7% | 17.9% | ||
| Q3 25 | 0.0% | 36.5% | ||
| Q2 25 | 1.4% | 49.3% | ||
| Q1 25 | 1.1% | 45.8% | ||
| Q4 24 | -1.2% | 66.4% | ||
| Q3 24 | 3.4% | 27.8% | ||
| Q2 24 | 3.9% | 22.4% | ||
| Q1 24 | 3.7% | 66.8% |
每股收益（稀释后）ASTHESS
| Q4 25 | $0.12 | $1.24 | ||
| Q3 25 | $0.01 | $2.56 | ||
| Q2 25 | $0.19 | $3.44 | ||
| Q1 25 | $0.14 | $3.16 | ||
| Q4 24 | $-0.14 | $4.00 | ||
| Q3 24 | $0.33 | $1.84 | ||
| Q2 24 | $0.40 | $1.45 | ||
| Q1 24 | $0.31 | $4.25 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $76.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $779.3M | $5.5B |
| 总资产 | $2.2B | $13.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASTHESS
| Q4 25 | $429.5M | $76.2M | ||
| Q3 25 | $463.4M | $66.0M | ||
| Q2 25 | $342.1M | $58.7M | ||
| Q1 25 | $260.9M | $98.7M | ||
| Q4 24 | $290.8M | $66.8M | ||
| Q3 24 | $350.3M | $71.3M | ||
| Q2 24 | $327.7M | $55.2M | ||
| Q1 24 | $337.3M | $499.0M |
总债务ASTHESS
| Q4 25 | — | — | ||
| Q3 25 | — | $6.4B | ||
| Q2 25 | — | $6.4B | ||
| Q1 25 | — | $6.8B | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $6.4B | ||
| Q2 24 | — | $6.2B | ||
| Q1 24 | — | $6.6B |
股东权益ASTHESS
| Q4 25 | $779.3M | $5.5B | ||
| Q3 25 | $775.5M | $5.6B | ||
| Q2 25 | $765.5M | $5.6B | ||
| Q1 25 | $745.4M | $5.6B | ||
| Q4 24 | $712.7M | $5.5B | ||
| Q3 24 | $704.6M | $5.4B | ||
| Q2 24 | $678.9M | $5.5B | ||
| Q1 24 | $653.5M | $5.5B |
总资产ASTHESS
| Q4 25 | $2.2B | $13.2B | ||
| Q3 25 | $2.2B | $13.2B | ||
| Q2 25 | $1.4B | $13.2B | ||
| Q1 25 | $1.3B | $13.2B | ||
| Q4 24 | $1.4B | $12.9B | ||
| Q3 24 | $1.3B | $12.6B | ||
| Q2 24 | $1.3B | $12.5B | ||
| Q1 24 | $1.2B | $12.9B |
负债/权益比ASTHESS
| Q4 25 | — | — | ||
| Q3 25 | — | 1.15× | ||
| Q2 25 | — | 1.14× | ||
| Q1 25 | — | 1.22× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.18× | ||
| Q2 24 | — | 1.13× | ||
| Q1 24 | — | 1.19× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $1.1B |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | — |
| 自由现金流率自由现金流/营收 | -0.6% | — |
| 资本支出强度资本支出/营收 | 0.3% | — |
| 现金转化率经营现金流/净利润 | -0.44× | 12.53× |
| 过去12个月自由现金流最近4个季度 | $104.5M | — |
8季度趋势，按日历期对齐
经营现金流ASTHESS
| Q4 25 | $-2.9M | $1.1B | ||
| Q3 25 | $10.0M | $342.6M | ||
| Q2 25 | $90.9M | $216.1M | ||
| Q1 25 | $16.6M | $281.5M | ||
| Q4 24 | $-10.9M | $1.1B | ||
| Q3 24 | $34.0M | $316.2M | ||
| Q2 24 | $23.2M | $218.9M | ||
| Q1 24 | $6.0M | $314.9M |
自由现金流ASTHESS
| Q4 25 | $-6.0M | — | ||
| Q3 25 | $7.4M | — | ||
| Q2 25 | $89.5M | — | ||
| Q1 25 | $13.6M | — | ||
| Q4 24 | $-13.5M | — | ||
| Q3 24 | $31.7M | — | ||
| Q2 24 | $20.4M | — | ||
| Q1 24 | $5.6M | — |
自由现金流率ASTHESS
| Q4 25 | -0.6% | — | ||
| Q3 25 | 0.8% | — | ||
| Q2 25 | 13.7% | — | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | -2.0% | — | ||
| Q3 24 | 6.6% | — | ||
| Q2 24 | 4.2% | — | ||
| Q1 24 | 1.4% | — |
资本支出强度ASTHESS
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | 0.6% | — | ||
| Q1 24 | 0.1% | — |
现金转化率ASTHESS
| Q4 25 | -0.44× | 12.53× | ||
| Q3 25 | 26.69× | 1.98× | ||
| Q2 25 | 9.65× | 0.93× | ||
| Q1 25 | 2.48× | 1.32× | ||
| Q4 24 | — | 3.54× | ||
| Q3 24 | 2.11× | 2.52× | ||
| Q2 24 | 1.21× | 2.21× | ||
| Q1 24 | 0.40× | 1.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
ESS
暂无分部数据
